These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 24827915)
61. Microneedle-based drug delivery systems for transdermal route. Pierre MB; Rossetti FC Curr Drug Targets; 2014 Mar; 15(3):281-91. PubMed ID: 24144208 [TBL] [Abstract][Full Text] [Related]
62. Perspectives on Transdermal Electroporation. Ita K Pharmaceutics; 2016 Mar; 8(1):. PubMed ID: 26999191 [TBL] [Abstract][Full Text] [Related]
63. Transdermal drug delivery systems: skin perturbation devices. Brown MB; Traynor MJ; Martin GP; Akomeah FK Methods Mol Biol; 2008; 437():119-39. PubMed ID: 18369965 [TBL] [Abstract][Full Text] [Related]
64. Perspectives of Lipid-Based Drug Carrier Systems for Transdermal Delivery. Pradhan M; Srivastava S; Singh D; Saraf S; Saraf S; Singh MR Crit Rev Ther Drug Carrier Syst; 2018; 35(4):331-367. PubMed ID: 29972681 [TBL] [Abstract][Full Text] [Related]
65. Transdermal iontophoretic drug delivery: advances and challenges. Ita K J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291 [TBL] [Abstract][Full Text] [Related]
66. Topical and Transdermal Delivery of Drug-Loaded Nano/ Microsystems with Application of Physical Enhancement Techniques. Borgheti-Cardoso LN; Ângelo T; Gelfuso GM; Lopez RF; Gratieri T Curr Drug Targets; 2016; 17(13):1545-59. PubMed ID: 26477464 [TBL] [Abstract][Full Text] [Related]
67. An update on the application of physical technologies to enhance intradermal and transdermal drug delivery. Herwadkar A; Banga AK Ther Deliv; 2012 Mar; 3(3):339-55. PubMed ID: 22833994 [TBL] [Abstract][Full Text] [Related]
69. Electroporation as an efficient physical enhancer for skin drug delivery. Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Revilla-Vázquez AL J Clin Pharmacol; 2009 Nov; 49(11):1262-83. PubMed ID: 19717723 [TBL] [Abstract][Full Text] [Related]
70. Recent advances in transdermal drug delivery. Subedi RK; Oh SY; Chun MK; Choi HK Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297 [TBL] [Abstract][Full Text] [Related]
71. A linear theory of transdermal transport phenomena. Edwards DA; Langer R J Pharm Sci; 1994 Sep; 83(9):1315-34. PubMed ID: 7830250 [TBL] [Abstract][Full Text] [Related]
72. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics. Shah V; Choudhury BK AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615 [TBL] [Abstract][Full Text] [Related]
73. Skin permeabilization for transdermal drug delivery: recent advances and future prospects. Schoellhammer CM; Blankschtein D; Langer R Expert Opin Drug Deliv; 2014 Mar; 11(3):393-407. PubMed ID: 24392787 [TBL] [Abstract][Full Text] [Related]
74. Transdermal drug delivery with a pressure wave. Doukas AG; Kollias N Adv Drug Deliv Rev; 2004 Mar; 56(5):559-79. PubMed ID: 15019746 [TBL] [Abstract][Full Text] [Related]
75. Transdermal delivery of a approximately 13 kDa protein--an in vivo comparison of physical enhancement methods. Katikaneni S; Li G; Badkar A; Banga AK J Drug Target; 2010 Feb; 18(2):141-7. PubMed ID: 19772395 [TBL] [Abstract][Full Text] [Related]
76. Synergistic effect of enhancers for transdermal drug delivery. Mitragotri S Pharm Res; 2000 Nov; 17(11):1354-9. PubMed ID: 11205727 [TBL] [Abstract][Full Text] [Related]
77. Permeation enhancer strategies in transdermal drug delivery. Marwah H; Garg T; Goyal AK; Rath G Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687 [TBL] [Abstract][Full Text] [Related]
78. Percutaneous penetration of anticancer agents: Past, present and future. Ita K Biomed Pharmacother; 2016 Dec; 84():1428-1439. PubMed ID: 27802901 [TBL] [Abstract][Full Text] [Related]